Table 1 Demographics, clinical characteristics and medications of study subjects
Patient no/sex/age in years | Disease Duration in years | Type of Disease | Organ Involvement | Concurrent medications |
|---|---|---|---|---|
1/F/47 | 5 | limited | GI | - |
2/F/62 | 12 | diffuse | Lung,PAH,GI | CYC |
3/M/55 | 2 | limited | Lung,GI | - |
4/F/53 | 12 | diffuse | Lung,DU,GI | MMF, Bos |
5/F/53 | 12 | limited | Lung,DU,GI | Pred, RTX, Bos |
6/F/78 | 4 | diffuse | Lung,DU,PAH,Musc | Pred, Bos, RTX |
7/F/57 | 21 | limited | Lung,DU,GI | Pred, Bos |
8/F/58 | 3 | diffuse | Lung,GI | RTX |
9/F/66 | 9 | limited | Lung,GI | MMF |
10/F/59 | 17 | limited | Musc | – |
11/F/65 | 8 | limited | Lung,GI | RTX |
12/F/40 | 22 | diffuse | Lung,GI,Musc | RTX |
13/F/81 | 15 | limited | GI | – |